Q2043
Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion
- Release
- October 2026
- Effective
Official Coding Notes
Reproduced verbatim from the October 2026 HCPCS Level II files.
Note
NCD Pub 100-3, 110.22.
Version History
How Q2043 appears in each release imported from the official files, newest first.
-
October 2026 Effective
CurrentSipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion
-
July 2026 Effective
UnchangedSipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion
-
April 2026 Effective
UnchangedSipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion
-
January 2026 Effective
UnchangedSipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion
Data Source
Code information on this page is derived from the October 2026 HCPCS Level II files published by CMS.
- Release
- October 2026
- Effective
- Source file
- october-2026-alpha-numeric-hcpcs-file.zip
Official HCPCS Level II source files (opens in a new tab)
MedCodeSearch is an independent reference service and is not affiliated with CMS, CDC, or the U.S. government.
Look up another code
Search ICD-10-CM, ICD-10-PCS and HCPCS Level II by code or description.